Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04620278 · ClinicalTrials.gov registry record
Genetic Investigation of Cancer Predisposition
A clinical trial, sponsored by The University of Texas Health Science Center at San Antonio.
- Not yet
- Registry status
- 100
- Enrollment target
NCT04620278: Clinical Trial study, sponsored by The University of Texas Health Science Center at San Antonio.
NCT04620278 is a clinical trial that has not yet begun recruiting, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04620278 has not yet begun recruiting, sponsored by The University of Texas Health Science Center at San Antonio.
- NOT YET RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
Clinical information and samples (blood, saliva, and tumor) will be collected from patients with multiple cancers and/or a family history of cancer as well as from affected and unaffected relatives; samples will be systematically sequenced and evaluated for candidate driver mutations.
Primary Outcome
Genetic screen detects a mutation that is likely responsible for tumor development
Interventions
- GENETIC DNA or RNA Sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-10 |
| Est. Completion | 2035-12 |
What is known before NCT04620278 opens enrollment
NCT04620278 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which DNA or RNA Sequencing is the first listed.
NCT04620278 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04620278 about?
NCT04620278 is a clinical study titled "Genetic Investigation of Cancer Predisposition". Clinical information and samples (blood, saliva, and tumor) will be collected from patients with multiple cancers and/or a family history of cancer as well as from affected and unaffected relatives; samples will be systematically sequenced and evaluated for candidate driver mutations.
What is the current status of trial NCT04620278?
This trial is currently not yet recruiting. The enrollment target is 100 participants. The study started on 2026-10. Estimated completion is 2035-12.
What interventions are being tested in trial NCT04620278?
The interventions under investigation include: DNA or RNA Sequencing (GENETIC).
Who is sponsoring clinical trial NCT04620278?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia